regenerative medicine

 research | development | marketing

SOLID FOUNDATIONS

LAM Biotechnologies SA is a Swiss company, founded in February 2018. The company’s goals are the research, development and marketing of products and services in the field of regenerative medicine.

LAM Biotechnologies SA is developing on a solid foundation, set up by two families anchored in French-speaking Switzerland for several generations. They are active in particular in the industrial, financial, technological and biomedical fields.

A HIGH LEVEL OF REQUIREMENTS

Building on a standardized allogeneic cellular technology, specific biotechnological processes and pioneering know-how, LAM Biotechnologies SA develops innovative solutions for the treatment of chondral and tendon disorders, of traumatic and/or degenerative origin.

LAM Biotechnologies SA is managed by Mr. Alexis LAURENT, a pharmacist with solid experience in the industrialization and translational advancement of biological active ingredients for therapeutic purposes.

Through multiple collaborations with renowned academic institutions and care centers, both in Switzerland and internationally, LAM Biotechnologies SA sets itself a high level of scientific, regulatory and clinical requirements.

A MULTIDISCIPLINARY NETWORK

Thanks in particular to its internal skills and its multidisciplinary network, LAM Biotechnologies SA is intended to provide long-term support for preclinical and clinical research, the development of therapies and devices and the improvement of the quality of care offered in the musculoskeletal field. 

 

 

scientific works

Bio-Enhanced Neoligaments Graft Bearing FE002 Primary Progenitor Tenocytes

Allogeneic Tissue Engineering & Surgical Proofs-of-Concept for Hand Ligament Regenerative Medicine

Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects

Manufacturing Process Benchmarking and Parallel Functional Qualification